Want to see IN:VALIANTORG full AI Analyst Report?
Top Page
Valiant Organics Limited
(VALIANTORG)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹278.00
▼(-0.71% Downside)
Action:Reiterated
Date:06/18/26
The score is driven primarily by improving but still inconsistent financial performance (recovery in profitability and cash flow, but declining revenue and volatile margins/returns). Technicals are supportive with the stock trading above key moving averages, while valuation remains somewhat demanding at ~26x earnings without a dividend yield to support the case.
Positive Factors
Profitability recovery & cash generation
Net income turning positive with operating cash flow recovery indicates the business has re-established core profitability and cash generation. Over 2-6 months this supports reinvestment in plants, reduces refinancing pressure, and gives management optionality to stabilize operations and execute medium-term improvements.
Negative Factors
Multi-year revenue decline
Sustained top-line erosion reduces scale benefits and amplifies fixed-cost absorption, making margins more sensitive to demand swings. Unless the company arrests volume declines or secures higher-value product mix, lingering revenue contraction will constrain sustainable profitability and returns over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability recovery & cash generation
Net income turning positive with operating cash flow recovery indicates the business has re-established core profitability and cash generation. Over 2-6 months this supports reinvestment in plants, reduces refinancing pressure, and gives management optionality to stabilize operations and execute medium-term improvements.
Read all positive factors
Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)
Market Cap
₹9.13B
Dividend YieldN/A
Average Volume (3M)2.15K
Price to Earnings (P/E)16.8
Beta (1Y)0.98
Revenue Growth1.41%
EPS Growth946.38%
CountryIN
Employees1,073
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)11.86
Shares Outstanding28,034,610
10 Day Avg. Volume2,085
30 Day Avg. Volume2,152
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.75
Price to Sales (P/S)0.77
P/FCF Ratio12.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Valiant Organics Limited Business Overview & Revenue Model
Company Description
Founded in Mumbai, India, in 1984, Valiant Organics Limited operates as a chemical manufacturer, specializing in the production and distribution of specialty chemicals across India. Their diverse product portfolio encompasses a variety of chloroph...
How the Company Makes Money
Valiant Organics primarily makes money by manufacturing specialty chemical intermediates and selling them to business customers (B2B), including agrochemical, pharmaceutical, and other industrial chemical companies. Revenue is largely generated fr...
Valiant Organics Limited Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
64
Positive
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.39B | 7.19B | 7.23B | 10.52B | 11.53B |
| Gross Profit | 2.13B | 2.62B | 470.01M | 1.81B | 2.17B |
| EBITDA | 996.99M | 615.51M | 425.75M | 1.77B | 2.12B |
| Net Income | 332.36M | -37.36M | -83.91M | 881.21M | 1.13B |
Balance Sheet | |||||
| Total Assets | 12.31B | 11.83B | 12.48B | 12.39B | 11.92B |
| Cash, Cash Equivalents and Short-Term Investments | 21.43M | 131.53M | 71.02M | 456.71M | 499.47M |
| Total Debt | 2.56B | 2.49B | 2.57B | 2.74B | 3.63B |
| Total Liabilities | 4.71B | 4.58B | 5.19B | 4.99B | 5.43B |
| Stockholders Equity | 7.59B | 7.25B | 7.29B | 6.89B | 6.13B |
Cash Flow | |||||
| Free Cash Flow | 439.27M | 256.03M | 90.70M | 862.19M | -1.53B |
| Operating Cash Flow | 774.59M | 564.32M | 840.00M | 2.38B | -307.47M |
| Investing Cash Flow | -898.89M | -209.61M | -649.88M | -1.43B | -1.24B |
| Financing Cash Flow | 71.27M | -318.13M | -231.19M | -1.12B | 1.67B |
Valiant Organics Limited Technical Analysis
Positive
280.00
Price Trends
282.11
Positive
277.61
Positive
268.97
Positive
Market Momentum
13.02
Negative
65.79
Neutral
91.28
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Positive. The current price of 280 is below the 20-day moving average (MA) of 284.64, below the 50-day MA of 282.11, and above the 200-day MA of 268.97, indicating a bullish trend. The MACD of 13.02 indicates Negative momentum. The RSI at 65.79 is Neutral, neither overbought nor oversold. The STOCH value of 91.28 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VALIANTORG.
Valiant Organics Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹9.44B | 11.71 | ― | 0.38% | 13.23% | 21.18% | |
65 Neutral | ₹422.38B | 53.41 | ― | 0.20% | 42.43% | 115.65% | |
62 Neutral | ₹13.46B | 20.52 | ― | 0.27% | 8.15% | 41.80% | |
58 Neutral | ₹70.94B | 21.48 | ― | 0.47% | 12.01% | 23.71% | |
56 Neutral | ₹9.13B | 16.82 | ― | ― | 1.41% | 946.38% | |
56 Neutral | ₹235.03B | 30.01 | ― | 0.45% | 8.20% | 29.06% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:VALIANTORG
Valiant Organics Limited
325.75
-41.75
-11.36%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,723.20
-78.97
-4.38%
IN:INDIAGLYCO
India Glycols Limited
1,058.35
178.34
20.27%
IN:INDOAMIN
Indo Amines Limited
130.05
-18.78
-12.62%
IN:NAVINFLUOR
Navin Fluorine International Limited
8,233.40
3,201.87
63.64%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
1,097.75
-119.20
-9.80%
Valiant Organics Limited Corporate Events
Valiant Organics Closes Trading Window Ahead of Quarterly Results
Jun 26, 2026
Valiant Organics Limited has announced the closure of its trading window for dealings in the company’s securities by directors, promoters, designated persons, connected persons, and their immediate relatives from July 1, 2026. The window wil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.